Aims: The economic burden of endometriosis and pelvic pain involves direct and indirect healthcare costs due to work loss and decreased productivity. However, the relation between endometriosis, pelvic pain, and employment remains underinvestigated. This study aimed at providing preliminary insights into this topic. Methods: We compared the employment status (having vs. not having a job) in 298 consecutive endometriosis patients and in 332 women without a history of endometriosis (control group). We also examined the association between pelvic pain and employment status. Results: Women with endometriosis were less likely to be employed compared to women without endometriosis (OR 0.508; 95% CI 0.284–0.908; p = 0.022). Women with symptomatic endometriosis were less likely to be employed relative to controls (OR 0.345; 95% CI 0.184–0.650; p = 0.001), as well as to asymptomatic endometriosis patients (OR 0.362; 95% CI 0.167–0.785; p = 0.01). No significant differences emerged between asymptomatic endometriosis and the control group (p > 0.05). Greater severity of dysmenorrhea, dyspareunia, chronic pelvic pain, and dyschezia was found in unemployed endometriosis patients (vs. employed endometriosis participants). Conclusion: Endometriosis symptoms may significantly affect women’s professional life, with important socioeconomic, legal, and political implications. Community-based participatory research is encouraged.

Keywords:
Endometriosis, Pelvic pain, Employment, Endometriosis symptoms, Impact of endometriosis
1.
Bulletti C, Coccia ME, Battistoni S, Borini A: Endometriosis and infertility. J Assist Reprod Genet 2010; 27: 441–447.
2.
Vercellini P, Fedele L, Aimi G, Pietropaolo G, Consonni D, Crosignani PG: Association between endometriosis stage, lesion type, patient characteristics and severity of pelvic pain symptoms: a multivariate analysis of over 1000 patients. Hum Reprod 2007; 22: 266–271.
3.
Facchin F, Barbara G, Saita E, Mosconi P, Roberto A, Fedele L, Vercellini P: Impact of endometriosis on quality of life and mental health: pelvic pain makes the difference. J Psychosom Obstet Gynaecol 2015; 36: 135–141.
4.
Facchin F, Saita E, Barbara G, Dridi D, Vercellini P: “Free butterflies will come out of these deep wounds”: a grounded theory of how endometriosis affects women’s psychological health. J Health Psych 2018; 23: 538–549.
5.
Pope CJ, Sharma V, Sharma S, Mazmanian D: A systematic review of the association between psychiatric disturbances and endometriosis. J Obstet Gynaecol Can 2015; 37: 1006–1015.
6.
De Graaff AA, D’Hooghe TM, Dunselman GA, Dirksen CD, Hummelshoj L, WERF EndoCost Consortium, Simoens S: The significant effect of endometriosis on physical, mental and social wellbeing: results from an international cross-sectional survey. Hum Reprod 2013; 28: 2677–2685.
7.
Facchin F, Barbara G, Dridi D, Alberico D, Buggio L, Somigliana E, Saita E, Vercellini P: Mental health in women with endometriosis: searching for predictors of psychological distress. Hum Reprod 2017; 9: 1855–1861.
8.
Hansen KE, Kesmodel US, Baldursson EB, Schultz R, Forman A: The influence of endometriosis-related symptoms on work life and work ability: a study of Danish endometriosis patients in employment. Eur J Obstet Gynecol Reprod Biol 2013; 169: 331–339.
9.
Soliman AM, Taylor H, Bonafede M, Nelson JK, Castelli-Haley J: Incremental direct and indirect cost burden attributed to endometriosis surgeries in the United States. Fert Steril 2017; 107: 1181–1190.
10.
Fourquet J, Gao X, Zavala D, Orengo JC, Abac S, Ruiz A, Laboy J, Flores I: Patients’ report on how endometriosis affects health, work, and daily life. Fert Steril 2010; 93: 2424–2428.
11.
Simoens S, Dunselman G, Dirksen C, Hummelshoj L, Bokor A, Brandes I, et al: The burden of endometriosis costs and quality of life of women with endometriosis treated in referral centres. Hum Reprod 2012; 27: 1292–1299.
12.
Prast J, Oppelt P, Shamiyeh A, Shebl O, Brandes I, Haas D: Costs of endometriosis in Austria: a survey of direct and indirect costs. Arch Gynecol Obstet 2013; 288: 569–576.
13.
Simoens S, Hummelshoj L, Dunselman G, Brandes I, Dirksen C, D’Hooghe T, EndoCost Consortium: endometriosis cost assessment (the EndoCost study): a cost-of-illness protocol. Gynecol Obstet Invest 2011; 71: 170–176.
14.
Simoens S, Meuleman C, D’Hooghe T: Non-health-care costs associated with endometriosis. Hum Reprod 2011; 26: 2363–2367.
15.
Soliman AM, Surrey E, Bonafede M, Nelson JK, Castelli-Haley J: Real-world evaluation of direct and indirect economic burden among endometriosis patients in the United States. Adv Ther 2018; 35: 408–423.
16.
Hummelshoj L: Endometriosis: an old problem without a current solution. Acta Obstet Gynecol Scand 2017; 96: 779–782.
17.
Nnoaham KE, Hummelshoj L, Webster P, d’Hooghe T, de Cicco Nardone F, et al: Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries. Fertil Steril 2011; 96: 366–373.
18.
Nisenblat V, Bossuyt PM, Farquhar C, Johnson N, Hull ML: Imaging modalities for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev 2016; 2:CD009591.
19.
Somigliana E, Vercellini P, Viganò P, Benaglia L, Crosignani PG, Fedele L: Non-invasive diagnosis of endometriosis: the goal or own goal? Hum Reprod 2010; 25: 1863–1868.
20.
Vercellini P, Giudice LC, Evers JL, Abrao MS: Reducing low-value care in endometriosis between limited evidence and unresolved issues: a proposal. Hum Reprod 2015; 30: 1996–2004.
21.
Soliman AM, Yang H, Du EX, Kelly C, Winkel C: The direct and indirect costs associated with endometriosis: a systematic literature review. Hum Reprod 2016; 31: 712–722.
22.
Gao X, Outley J, Botteman M, Spalding J, Simon JA, Pashos CL: Economic burden of endometriosis. Fertil Steril 2006; 86: 1561–1572.
23.
Fourquet J, Báez L, Figueroa M, Iriarte RI, Flores I: Quantification of the impact of endometriosis symptoms on health-related quality of life and work productivity. Fertil Steril 2011; 96: 107–112.
24.
Soliman AM, Taylor HS, Bonafede M, Nelson JK, Castelli-Haley J: Incremental direct and indirect cost burden attributed to endometriosis surgeries in the United States. Fertil Steril 2017; 107: 1181–1190.
25.
Soliman AM, Coyne KS, Gries KS, Castelli-Haley J, Snabes MC, Surrey ES: The effect of endometriosis symptoms on absenteeism and presenteeism in the workplace and at home. J Manag Care Spec Pharm 2017; 23: 745–754.
26.
Ferrero S, Camerini G, Seracchioli R, Ragni N, Venturini R, Remorgida V: Letrozole combined with norethisterone acetate compared with norethisterone acetate alone in treatment of pain symptoms cause by endometriosis. Hum Reprod 2009; 24: 3033–3041.
27.
Bianconi L, Hummelshoj L, Coccia ME, Viganò P, Vittori G, Veit J, Music R, Tomassini A, D’Hooghe T: Recognizing endometriosis as a social disease: the European Union-encouraged Italian senate approach. Fert Ster 2007; 85: 1285–1287.
28.
Johnson NP, Hummelshoj L; World Endometriosis Society Montpellier Consortium: Consensus on current management of endometriosis. Hum Reprod 2013; 28: 1552–1568.
29.
Wallis D, Bowis J, Tannock C, Stihler C, Lambert J: European Parliament Written Declaration on Endometriosis. P6_DCL(2005)0013.
30.
Israel BA, Schulz AJ, Parker EA, Becker AB: Review of community-based research: assessing partnership approaches to improve public health. Annu Rev Public Health 1998; 19: 173–202.
31.
Riffin C, Kenien C, Ghesquiere A, Dorime A, Villanueva C, Gardner D, et al: Community-based participatory research: understanding a promising approach to addressing knowledge gaps in palliative care. Ann Palliat Med 2016; 5: 218–224.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.